Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product

Abstract

We recently isolated a cDNA for hpttg, the human homolog of rat pituitary tumor transforming gene. Now we have analysed the expression of hpttg as a function of cell proliferation. hPTTG protein level is up-regulated in rapidly proliferating cells, is down-regulated in response to serum starvation or cell confluence, and is regulated in a cell cycle-dependent manner, peaking in mitosis. In addition, we show that hPTTG is phosphorylated during mitosis. Immunodepletion and in vitro phosphorylation experiments, together with the use of a specific inhibitor, indicate that Cdc2 is the kinase that phosphorylates hPTTG. These results suggest that hpttg is induced by, and may have a role in, regulatory pathways involved in the control of cell proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bailly E, McCaffrey M, Touchot N, Zahraoui A, Goud B and Bornens M. . 1991 Nature 350: 715–718.

  • Belenguer P, Caizergues-Ferrer M, Labbe JC, Doree M and Amalric F. . 1990 Mol. Cell Biol. 10: 3607–3618.

  • Bradbury EM. . 1992 Bioessays 14: 9–16.

  • Brinkmann U, Brinkmann E, Gallo M and Pastan I. . 1995 Proc. Natl. Acad. Sci. USA 92: 10427–10431.

  • Buday L, Warne PH and Downward J. . 1995 Oncogene 11: 1327–1331.

  • Buendia B, Clarke PR, Felix MA, Karsenti E, Leiss D and Verde F. . 1991 Cold Spring Harb. Symp. Quant. Biol. 56: 523–532.

  • Chou YH, Bischoff JR, Beach D and Goldman RD. . 1990 Cell 62: 1063–1071.

  • Colgan DF, Murthy KG, Zhao W, Prives C and Manley JL. . 1998 EMBO J. 17: 1053–1062.

  • Corbalan-Garcia S, Yang SS, Degenhardt KR and Bar-Sagi D. . 1996 Mol. Cell Biol. 16: 5674–5682.

  • Domínguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M and Pintor-Toro JA. . 1998 Oncogene 17: 2187–2193.

  • Gottesfeld JM and Forbes DJ. . 1997 Trends Biochem. Sci. 22: 197–202.

  • Heichman KA and Roberts JM. . 1994 Cell 79: 557–562.

  • Hershkovitz M and Riggs AD. . 1995 Proc. Natl. Acad. Sci. USA 92: 2379–2383.

  • Hirama T and Koeffler HP. . 1995 Blood 86: 841–854.

  • Hsu SC, Qi M and DeFranco DB. . 1992 EMBO J. 11: 3457–3468.

  • Jackman MR and Pines JN. . 1997 Cancer Surv. 29: 47–73.

  • Jin DY, Spencer F and Jeang KT. . 1998 Cell 93: 81–91.

  • King RW, Jackson PK and Kirschner MW. . 1994 Cell 79: 563–571.

  • Laemmli UK. . 1970 Nature 227: 680–685.

  • Luscher B and Eisenman RN. . 1992 J. Cell Biol. 118: 775–784.

  • Martínez-Balbás MA, Dey A, Rabindran SK, Ozato K and Wu C. . 1995 Cell 83: 29–38.

  • Moreno S and Nurse P. . 1990 Cell 61: 549–551.

  • Morgan DO. . 1995 Nature 374: 131–134.

  • Morgan DO. . 1997 Annu. Rev. Cell Dev. Biol. 13: 261–291.

  • Nigg EA. . 1991 Semin. Cell. Biol. 2: 261–270.

  • Nigg EA. . 1995 Bioessays 17: 471–480.

  • Nurse P. . 1994 Cell 79: 547–550.

  • Pei L. . 1998 J. Biol. Chem. 273: 5219–5225.

  • Pei L. . 1999 J. Biol. Chem. 274: 3151–3158.

  • Pei L and Melmed S. . 1997 Mol. Endocrinol. 11: 433–441.

  • Peter M, Nakagawa J, Doree M, Labbe JC and Nigg EA. . 1990a Cell 60: 791–801.

  • Peter M, Nakagawa J, Doree M, Labbe JC and Nigg EA. . 1990b Cell 61: 591–602.

  • Pines J. . 1995 Adv. Cancer Res. 66: 181–212.

  • Reed SI. . 1997 Cancer Surv. 29: 7–23.

  • Sáez C, Japón MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M and Pintor-Toro JA. . 1999 Oncogene 18: 5473–5476.

  • Satterwhite LL, Lohka MJ, Wilson KL, Scherson TY, Cisek LJ, Corden JL and Pollard TD. . 1992 J. Cell Biol. 118: 595–605.

  • Sherr CJ. . 1994 Cell 79: 551–555.

  • Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.

  • Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H and Cantley LC. . 1994 Curr. Biol. 4: 973–982.

  • Tuomikoski T, Felix MA, Doree M and Gruenberg J. . 1989 Nature 342: 942–945.

  • Verde F, Labbe JC, Doree M and Karsenti E. . 1990 Nature 343: 233–238.

  • Yamashiro S and Matsumura F. . 1991 Bioessays 13: 563–568.

  • Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD and Melmed S. . 1999a J. Clin. Endocrinol. Metab. 84: 761–767.

  • Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD and Melmed S. . 1999b Mol. Endocrinol. 13: 156–166.

  • Zou H, McGarry TJ, Bernal T and Kirschner MW. . 1999 Science 285: 418–422.

Download references

Acknowledgements

We thank Dr RM Rios for useful discussions and suggestions and Drs S Gisselbrecht and S Fischer for critical reading of the manuscript. This work was supported by grants from Ministerio de Educación y Ciencia of Spain (SAF96-0275 and SAF99-0125), from DGUI of the Junta de Andalucía, and from Rhône-Poulenc Rorer (Paris).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramos-Morales, F., Domínguez, Á., Romero, F. et al. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene 19, 403–409 (2000). https://doi.org/10.1038/sj.onc.1203320

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203320

Keywords

This article is cited by

Search

Quick links